BioAge Labs, Inc. (BIOA)
6.35
+0.14
(+2.25%)
USD |
NASDAQ |
Oct 09, 16:00
6.35
0.00 (0.00%)
After-Hours: 20:00
BioAge Labs Price to Book Value : 0.7753 for Oct. 9, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 08, 2026 | 0.7582 |
| October 07, 2026 | 0.7643 |
| October 06, 2026 | 0.768 |
| October 05, 2026 | 0.7766 |
| October 02, 2026 | 0.8071 |
| October 01, 2026 | 0.8315 |
| September 30, 2026 | 0.8657 |
| September 29, 2026 | 0.8718 |
| September 28, 2026 | 0.8767 |
| September 25, 2026 | 0.8608 |
| September 24, 2026 | 0.8803 |
| September 23, 2026 | 0.9634 |
| September 22, 2026 | 1.033 |
| September 21, 2026 | 0.9878 |
| September 18, 2026 | 0.9841 |
| September 17, 2026 | 0.9878 |
| September 16, 2026 | 0.9463 |
| September 15, 2026 | 0.9988 |
| September 14, 2026 | 1.035 |
| September 11, 2026 | 1.037 |
| September 10, 2026 | 1.056 |
| September 09, 2026 | 1.120 |
| September 08, 2026 | 1.147 |
| September 04, 2026 | 1.171 |
| September 03, 2026 | 1.16 |
| Date | Value |
|---|---|
| September 02, 2026 | 1.188 |
| September 01, 2026 | 1.162 |
| August 31, 2026 | 1.16 |
| August 28, 2026 | 1.178 |
| August 27, 2026 | 1.231 |
| August 26, 2026 | 1.202 |
| August 25, 2026 | 1.234 |
| August 24, 2026 | 1.145 |
| August 21, 2026 | 1.158 |
| August 20, 2026 | 1.183 |
| August 19, 2026 | 1.313 |
| August 18, 2026 | 1.277 |
| August 17, 2026 | 1.270 |
| August 14, 2026 | 1.294 |
| August 13, 2026 | 1.274 |
| August 12, 2026 | 1.280 |
| August 11, 2026 | 1.303 |
| August 10, 2026 | 1.398 |
| August 07, 2026 | 1.431 |
| August 06, 2026 | 1.376 |
| August 05, 2026 | 1.341 |
| August 04, 2026 | 1.368 |
| August 03, 2026 | 1.316 |
| July 31, 2026 | 1.104 |
| July 30, 2026 | 3.034 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Neumora Therapeutics, Inc. | 1.989 |
| Alumis, Inc. | 2.036 |
| ANI Pharmaceuticals, Inc. | 2.843 |
| Corcept Therapeutics, Inc. | 18.51 |
| Veru, Inc. | 1.487 |
Price to Book Value Related Metrics
| PS Ratio | 24.42 |
| PEG Ratio | -0.3942 |
| Price | 6.35 |
| Earnings Yield | -37.59% |
| Market Cap | 290.68M |
| PEGY Ratio | -0.3942 |